PHI with Tetralogy of Fallot

Read in German: PKV mit Fallot V

How does this condition affect your private health insurance?

Pentalogy of Fallot, sometimes referred to as Fallot V, is a complex congenital heart defect characterized by five co-occurring abnormalities: a ventricular septal defect (VSD), pulmonary stenosis, an overriding aorta, right ventricular hypertrophy, and an atrial septal defect (ASD). This combination leads to cyanosis, as deoxygenated blood bypasses the lungs and mixes with oxygenated blood, causing a bluish tint to the skin. Symptoms typically manifest in infancy, including shortness of breath, feeding difficulties, and clubbing of fingers. Early diagnosis and surgical intervention are crucial to improve prognosis, as the condition significantly impairs cardiac function and overall development.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Weeks to months, presenting acutely or subacutely during infancy, leading to diagnosis and intervention.

Duration of Illness (Lifetime)

Chronic, lifelong condition requiring early surgical correction and ongoing cardiac follow-up and management.

Cost of Treatment (Initial)

High, typically hundreds of thousands of USD for initial diagnosis, stabilization, and complex open-heart surgery (e.g., $100,000 - $300,000+).

Cost of Treatment (Lifetime)

Very high, potentially exceeding several hundred thousand to millions of USD over a lifetime due to follow-ups, potential re-interventions, medications, and management of residual defects or complications.

Mortality Rate

Without surgical intervention, very high (e.g., 50-70% mortality by age 1, higher by age 5). With timely and successful surgery, significantly reduced but still a low to moderate risk (e.g., 2-5% perioperative mortality, and ongoing long-term risks).

Risk of Secondary Damages

Moderate to high. Potential for developmental delays, persistent pulmonary hypertension, arrhythmias, heart failure, residual valve dysfunction, and endocarditis over a lifetime.

Probability of Full Recovery

Low to moderate for complete recovery without any long-term consequences. Most patients achieve good functional outcomes after surgery but require lifelong monitoring and may have residual defects or complications.

Underlying Disease Risk

Moderate. Can be associated with genetic syndromes like DiGeorge syndrome (22q11.2 deletion), Down syndrome (Trisomy 21), or other chromosomal abnormalities.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.